Bioinformatics and Biology Insights

Scope & Guideline

Bridging computational methods with biological breakthroughs.

Introduction

Welcome to your portal for understanding Bioinformatics and Biology Insights, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1177-9322
PublisherSAGE PUBLICATIONS LTD
Support Open AccessYes
CountryNew Zealand
TypeJournal
Convergefrom 2009 to 2024
AbbreviationBIOINFORM BIOL INSIG / Bioinform. Biol. Insights
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The journal "Bioinformatics and Biology Insights" primarily focuses on the intersection of bioinformatics and biological research, leveraging computational tools and methodologies to advance understanding in various biological systems and diseases. Its core areas include:
  1. Bioinformatics and Computational Biology:
    Utilization of computational methods to analyze biological data, including genomic, transcriptomic, and proteomic datasets, to derive insights into biological processes and disease mechanisms.
  2. Disease Mechanism and Therapeutics:
    Investigation of the molecular underpinnings of diseases, including cancer, infectious diseases, and autoimmune disorders, often involving identification of biomarkers and therapeutic targets.
  3. Systems Biology:
    Integration of biological data from multiple sources to understand complex interactions within biological systems and to model biological processes.
  4. Machine Learning and AI Applications:
    Application of machine learning techniques to predict biological outcomes, identify drug candidates, and enhance the analysis of biological data.
  5. Omics Research:
    Focus on various omics studies (genomics, proteomics, metabolomics) to explore the molecular basis of health and disease, and to identify potential therapeutic strategies.
  6. Pharmacoinformatics and Drug Discovery:
    Exploration of computational approaches for drug discovery, including molecular docking, virtual screening, and the design of novel therapeutic compounds.
  7. Epidemiological and Environmental Studies:
    Research that incorporates bioinformatics to study the epidemiology of infectious diseases and the impact of environmental factors on health.
  8. Bioinformatics Tools Development:
    Creation and enhancement of bioinformatics tools and databases to facilitate the analysis of biological data and improve research methodologies.
Recent publications in "Bioinformatics and Biology Insights" highlight several trending and emerging themes that reflect the evolving landscape of bioinformatics research. The following areas are gaining traction and are likely to shape future research directions:
  1. Integrative Multi-Omics Approaches:
    There is a growing trend towards integrating various omics data (genomics, transcriptomics, proteomics) to better understand complex biological systems and diseases.
  2. Artificial Intelligence in Drug Discovery:
    The application of AI and machine learning techniques for drug discovery and development is rapidly increasing, with numerous studies focusing on predictive modeling and virtual screening.
  3. COVID-19 Related Research:
    Given the ongoing impact of the COVID-19 pandemic, there is a significant increase in research related to SARS-CoV-2, including studies on variants, vaccine development, and therapeutic targets.
  4. Personalized Medicine and Biomarker Discovery:
    Research aimed at identifying biomarkers for personalized treatment approaches is on the rise, with a focus on tailoring therapies based on individual genetic profiles.
  5. Bioinformatics for Environmental and Epidemiological Studies:
    An emerging focus on utilizing bioinformatics tools to study the impact of environmental factors on health and to investigate epidemiological trends in infectious diseases.
  6. Phytochemical and Natural Product Studies:
    There is an increasing interest in the bioinformatics analysis of natural compounds for therapeutic applications, particularly for their potential antiviral and anticancer properties.
  7. Network Pharmacology:
    The application of network pharmacology to explore the interactions of drugs within biological networks is gaining importance as a means to understand multi-target drug effects.

Declining or Waning

While "Bioinformatics and Biology Insights" has a broad and dynamic focus, certain themes appear to be declining in prominence over recent publications. The following areas have seen a reduction in publications or interest:
  1. Traditional Experimental Approaches:
    There is a noticeable decline in studies relying solely on traditional laboratory techniques without the integration of computational methods, as the field increasingly values data-driven approaches.
  2. Basic Descriptive Studies:
    Research that merely describes biological phenomena without employing deeper computational analysis or hypothesis testing is becoming less common, as the field shifts towards more analytical studies.
  3. Standalone Bioinformatics Methods:
    Papers focusing exclusively on bioinformatics methods without application to biological questions or integration with experimental data are appearing less frequently.
  4. Single-Omics Studies:
    The focus is shifting away from single-omics studies, such as only genomics or proteomics, as integrative multi-omics approaches gain traction for a more comprehensive understanding of biological systems.

Similar Journals

Current Bioinformatics

Innovating Computational Techniques for Biological Insights
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1574-8936Frequency: 6 issues/year

Current Bioinformatics, an esteemed journal published by Bentham Science Publishers Ltd, serves as a pivotal platform for the dissemination of cutting-edge research in the fields of bioinformatics, biochemistry, computational mathematics, genetics, and molecular biology. With an ISSN of 1574-8936 and an E-ISSN of 2212-392X, this journal has established itself as a vital resource for researchers, professionals, and students keen on exploring interdisciplinary approaches to biological data analysis. Its prominence is reflected in its quartile rankings for 2023, where it stands in Q3 for biochemistry and computational mathematics, alongside Q4 rankings in genetics and molecular biology. Current Bioinformatics, located in the United Arab Emirates and converging from 2007 to 2024, aims to foster innovation in the field by presenting original research articles, reviews, and case studies that drive forward our understanding of complex biological systems through computational techniques. This journal is an integral resource for those wishing to stay at the forefront of bioinformatics research and applications.

BIOSCIENCE REPORTS

Your Gateway to Cutting-Edge Scientific Discoveries
Publisher: PORTLAND PRESS LTDISSN: 0144-8463Frequency: 6 issues/year

BIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.

ACS Bio & Med Chem Au

Exploring breakthroughs in pharmaceutical sciences and molecular biology.
Publisher: AMER CHEMICAL SOCISSN: Frequency: 6 issues/year

ACS Bio & Med Chem Au, published by the esteemed American Chemical Society, stands at the forefront of interdisciplinary research within the realms of biochemistry, drug discovery, pharmaceutical sciences, and molecular biology. With an impressive Impact Factor indicative of its rigorous academic standards and significant contributions to the field, this open-access journal is committed to disseminating high-quality research that drives innovation and advancements in biosciences and medicinal chemistry. Since its inception in 2021, the journal has rapidly earned recognition, achieving a commendable Q1 ranking in multiple categories, including Biochemistry, Drug Discovery, and Pharmaceutical Science, while also making strides in Molecular Biology. Researchers, professionals, and students alike can explore pioneering studies that bridge gaps between laboratory research and clinical applications, fostering collaborative efforts towards novel therapeutic strategies. With a focus on enhancing accessibility and engagement within the scientific community, ACS Bio & Med Chem Au is poised to impact the future of biomedical research significantly.

Current Proteomics

Navigating the Evolving Landscape of Proteomics
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1570-1646Frequency: 5 issues/year

Current Proteomics is a distinguished journal dedicated to the dynamic field of proteomics, offering researchers and professionals a platform to disseminate innovative findings and comprehensive reviews. Published by Bentham Science Publishers Ltd, this journal caters to a global audience and serves as an essential resource for students, academics, and industry experts interested in advances in biochemistry and molecular biology. With an ISSN of 1570-1646 and an E-ISSN of 1875-6247, the journal has established itself in various research categories, achieving a Q4 ranking in both Biochemistry and Molecular Biology as of 2023. While the impact factor and H-index data are not specified, its Scopus ranking reflects a competitive position in its fields, with percentiles in the 12th to 16th range. Although not an open-access journal, Current Proteomics is vital for fostering ongoing dialogue and collaboration in proteomic research, encouraging contributions that explore cutting-edge methodologies and applications. Researchers are invited to share their insights and contribute to this evolving discipline, thus enhancing the collective understanding of proteomics within the scientific community.

Network Modeling and Analysis in Health Informatics and Bioinformatics

Pioneering research at the crossroads of bioinformatics and health.
Publisher: SPRINGER WIENISSN: 2192-6662Frequency: 1 issue/year

Network Modeling and Analysis in Health Informatics and Bioinformatics, published by SPRINGER WIEN, stands as a vital resource in the interdisciplinary domains of health informatics and bioinformatics. With an ISSN of 2192-6662 and E-ISSN of 2192-6670, this journal aims to facilitate the dissemination of innovative research that intersects network modeling, data analysis, and health applications. The journal competes at a Q3 quartile level across multiple categories including Biomedical Engineering and Health Informatics, showcasing its growing influence within the academic community. As of 2023, it holds impressive Scopus rankings, including a 20th position in Urology, illustrating its significance in the field. Although not an open access publication, the journal is dedicated to providing cutting-edge insights from 2012 to 2024 and is poised to attract researchers, professionals, and students striving to push the boundaries of knowledge in health informatics and bioinformatics. This journal is not just a platform for sharing scholarly articles; it is a catalyst for advancing methodologies that enhance patient care and medical research.

Briefings in Functional Genomics

Connecting Research and Discovery in Genomics
Publisher: OXFORD UNIV PRESSISSN: 2041-2649Frequency: 6 issues/year

Briefings in Functional Genomics, published by Oxford University Press, serves as a crucial academic resource in the fields of biochemistry, genetics, and molecular biology. With an ISSN of 2041-2649 and an E-ISSN of 2041-2657, this esteemed journal explores innovative research and developments in functional genomics, with a commitment to advancing our understanding of genetic processes and their implications in health and disease. Ranking in the Q2 quartile for both Biochemistry and Genetics, and occupying a prominent Q1 status in the domain of interdisciplinary Medicine, the journal is positioned as a leading platform for researchers seeking to disseminate their findings to a global audience. Although it does not currently offer open access options, its accessibility through institutional subscriptions and its esteemed impact factor underscore its importance in the research community. Covering converging topics from 2010 to 2024, Briefings in Functional Genomics not only keeps pace with the rapidly evolving landscape of genomics but also stimulates collaboration and dialogue among scientists and industry professionals alike, making it an indispensable tool for researchers, practitioners, and students eager to engage with cutting-edge genomic science.

COMPUTATIONAL BIOLOGY AND CHEMISTRY

Unraveling Complex Biological Mysteries with Computational Precision
Publisher: ELSEVIER SCI LTDISSN: 1476-9271Frequency: 6 issues/year

COMPUTATIONAL BIOLOGY AND CHEMISTRY is a distinguished academic journal published by Elsevier Science Ltd, focusing on the dynamic intersection of computational biology, biochemistry, and chemistry. With an ISSN of 1476-9271 and an E-ISSN of 1476-928X, this journal is committed to disseminating high-quality research that employs computational techniques to solve complex biological and chemical problems. As of 2023, the journal holds a substantial impact factor reflecting its significance and rigorous peer-review process, categorized in the Q2 quartile for both Computational Mathematics and Organic Chemistry, alongside Q3 classifications in Biochemistry and Structural Biology. With a continuous publication history spanning from 2003 to 2024, it serves as a critical resource for researchers, professionals, and students alike. The journal offers various open access options, ensuring that vital research findings are accessible to a global audience, further enhancing collaboration across disciplines. Engage with cutting-edge studies and contribute to the evolving landscape of computational methodologies in the life sciences through this esteemed publication.

JOURNAL OF COMPUTATIONAL BIOLOGY

Bridging Biology and Computation for a Deeper Understanding
Publisher: MARY ANN LIEBERT, INCISSN: 1066-5277Frequency: 12 issues/year

JOURNAL OF COMPUTATIONAL BIOLOGY, published by Mary Ann Liebert, Inc., serves as a premier platform for the dissemination of groundbreaking research at the intersection of biological sciences and computational methods. Established in 1994, this journal provides a valuable resource for researchers, professionals, and students interested in the evolving fields of computational mathematics and biology. With a commendable Q2 ranking in several pertinent categories such as Computational Mathematics and Modeling and Simulation, it emphasizes high-quality studies that propel understanding and innovation in these areas. Although the journal currently operates under traditional access options, it plays a crucial role in fostering scholarly communication and collaboration among a diverse audience, advancing knowledge in genetics, molecular biology, and beyond. The journal's continual evolution, with a commitment to publish until at least 2024, positions it as a critical resource in the fast-paced world of computational biology.

GENERAL PHYSIOLOGY AND BIOPHYSICS

Empowering Scholars in the Study of Life's Dynamics
Publisher: AEPRESS SROISSN: 0231-5882Frequency: 4 issues/year

GENERAL PHYSIOLOGY AND BIOPHYSICS, published by AEPRESS SRO, is a pivotal journal in the fields of biophysics and physiology, dedicated to advancing knowledge and fostering research in these increasingly vital disciplines. Established in 1983 and set to converge in 2024, the journal provides a platform for scholarly articles that explore the intricate relationships between biological systems and physical principles. Its current category quartiles include Q3 in Biophysics and Q4 in Physiology, demonstrating a growing influence among researchers, with current Scopus ranks reflecting its commitment to quality and relevance. Despite not being an open-access publication, the journal remains a valuable resource for professionals and students aiming to stay informed on the latest discoveries and methodologies. By supporting interdisciplinary research and innovation, GENERAL PHYSIOLOGY AND BIOPHYSICS plays a crucial role in shaping the understanding of complex biological interactions and applications in medicine.

npj Systems Biology and Applications

Integrating Science for a Healthier Tomorrow
Publisher: NATURE PORTFOLIOISSN: Frequency: 1 issue/year

npj Systems Biology and Applications, published by NATURE PORTFOLIO, is a premier open-access journal that has been at the forefront of the field since its inception in 2015. With a commendable focus on the interdisciplinary integration of applied mathematics, biochemistry, computer science, and drug discovery, the journal currently enjoys a Q1 ranking across multiple categories, showcasing its significant impact within the scientific community. In 2023, it ranked 70 out of 635 in Applied Mathematics and holds a notable place in the 89th percentile, confirming its esteemed reputation among researchers. Situated in the United Kingdom, this journal not only promotes innovative research in systems biology but also serves as an essential platform for the dissemination of high-quality studies that delve into modeling, simulation, and the application of biological systems in drug discovery processes. With an open-access model, authors can reach a broad audience, enhancing collaborations and advancing knowledge across disciplines, making it an indispensable resource for researchers, professionals, and students alike seeking to contribute to the evolving landscape of systems biology.